Q4 2023 Holdings
Filed 2024-02-14 | 74 holdings | $2.7B | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↑ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Nuvation BIO Inc(NUVB/WS) | *W EXP 07/07/202 | 67080N119 | $5.4K | 89,543 | 0.0% |
| Caremax Inc | COM CL A | 14171W103 | $316.9K | 636,000 | 0.0% |
| Amylyx Pharmaceuticals Inc(AMLX) | COM | 03237H101 | $949.5K | 64,501 | 0.0% |
| Hyperfine Inc(HYPR) | COM CL A | 44916K106 | $1.3M | 1,188,178 | 0.0% |
| Revolution Medicines Inc(RVMD) | COM | 76155X100 | $1.7M | 60,000 | 0.1% |
| Compass Therapeutics Inc(CMPX) | COM | 20454B104 | $2.5M | 1,599,600 | 0.1% |
| Scynexis Inc(SCYX) | COM NEW | 811292200 | $3.2M | 1,448,728 | 0.1% |
| Century Therapeutics Inc(IPSC) | COM | 15673T100 | $4.5M | 1,355,000 | 0.2% |
| Kezar Life Sciences Inc | COM | 49372L100 | $4.8M | 5,025,454 | 0.2% |
| Akero Therapeutics Inc(AKRO) | COM | 00973Y108 | $5.5M | 235,000 | 0.2% |
| Karyopharm Therapeutics Inc(KPTIEUR) | COM | 48576U106 | $7.2M | 8,298,570 | 0.3% |
| Travere Therapeutics Inc(TVTX) | COM | 89422G107 | $7.4M | 827,010 | 0.3% |
| Neurogene Inc(NGNE) | COM | 64135M105 | $9.0M | 466,243 | 0.3% |
| Immunovant Inc(IMVT) | COM | 45258J102 | $10.3M | 245,000 | 0.4% |
| Collegium Pharmaceutical Inc(COLL) | COM | 19459J104 | $11.1M | 361,363 | 0.4% |
| Cerevel Therapeutics Hldng I(CERE1EUR) | COM | 15678U128 | $11.7M | 276,888 | 0.4% |
| Argenx SE(ARGX) | SPONSORED ADR | 04016X101 | $11.8M | 31,000 | 0.4% |
| Dianthus Therapeutics Inc(DNTH) | COM | 252828108 | $12.7M | 1,217,554 | 0.5% |
| Syros Pharmaceuticals Inc(SYRS) | COM NEW | 87184Q206 | $13.0M | 1,673,538 | 0.5% |
| Intellia Therapeutics Inc(NTLA) | COM | 45826J105 | $13.6M | 447,434 | 0.5% |
| Agilent Technologies Inc(A) | COM | 00846U101 | $13.8M | 99,000 | 0.5% |
| Immunome Inc(IMNM) | COM | 45257U108 | $14.3M | 1,333,479 | 0.5% |
| Verona Pharma PLC(VRNA) | SPONSORED ADS | 925050106 | $15.5M | 780,900 | 0.6% |
| Phathom Pharmaceuticals Inc(PHAT) | COM | 71722W107 | $15.7M | 1,721,580 | 0.6% |
| Crinetics Pharmaceuticals in(CRNX) | COM | 22663K107 | $18.8M | 529,000 | 0.7% |
| Immunocore Hldgs PLC(IMCR) | ADS | 45258D105 | $20.5M | 300,200 | 0.7% |
| Arrowhead Pharmaceuticals in(ARWR) | COM | 04280A100 | $21.8M | 714,000 | 0.8% |
| AC Immune SA(ACIU) | SHS | H00263105 | $22.3M | 4,469,080 | 0.8% |
| An2 Therapeutics Inc(ANTX) | COM | 037326105 | $23.4M | 1,140,000 | 0.9% |
| Lantheus Hldgs Inc(LNTH) | COM | 516544103 | $23.6M | 380,000 | 0.9% |
| Structure Therapeutics Inc(GPCR)Call | SPONSORED ADS | 86366E106 | $24.5M | 600,000 | 0.9% |
| Intuitive Surgical Inc(ISRG) | COM NEW | 46120E602 | $28.7M | 85,000 | 1.0% |
| Privia Health Group Inc(PRVA) | COM | 74276R102 | $29.6M | 1,287,000 | 1.1% |
| Unitedhealth Group Inc(UNH) | COM | 91324P102 | $30.8M | 58,500 | 1.1% |
| Mirum Pharmaceuticals Inc(MIRM) | COM | 604749101 | $33.7M | 1,142,850 | 1.2% |
| Neumora Therapeutics Inc.(NMRA) | COM | 640979100 | $33.9M | 1,990,632 | 1.2% |
| Vaxcyte Inc(PCVX) | COM | 92243G108 | $35.8M | 570,137 | 1.3% |
| Caribou Biosciences Inc(CRBU) | COM | 142038108 | $36.4M | 6,360,212 | 1.3% |
| Axsome Therapeutics Inc(AXSM) | COM | 05464T104 | $36.6M | 459,400 | 1.3% |
| Surgery Partners Inc(SGRY) | COM | 86881A100 | $37.3M | 1,165,932 | 1.4% |
| Xenon Pharmaceuticals Inc(XENE) | COM | 98420N105 | $37.6M | 815,993 | 1.4% |
| Mckesson Corp(MCK) | COM | 58155Q103 | $39.6M | 85,500 | 1.4% |
| Ultragenyx Pharmaceutical in(RARE) | COM | 90400D108 | $40.4M | 844,500 | 1.5% |
| Becton Dickinson & Co(BDX) | COM | 075887109 | $40.4M | 165,706 | 1.5% |
| Legend Biotech Corp(LEGN) | SPONSORED ADS | 52490G102 | $41.2M | 685,000 | 1.5% |
| Align Technology Inc(ALGN) | COM | 016255101 | $42.7M | 155,800 | 1.6% |
| Structure Therapeutics Inc(GPCR) | SPONSORED ADS | 86366E106 | $44.0M | 1,080,000 | 1.6% |
| Abbvie Inc(ABBV) | COM | 00287Y109 | $44.1M | 284,405 | 1.6% |
| Humana Inc(HUM) | COM | 444859102 | $45.8M | 100,000 | 1.7% |
| Zoetis Inc(ZTS) | CL A | 98978V103 | $47.4M | 240,000 | 1.7% |